Sustained release hormonal preparations. 11. Biological effectiveness of (DL)-13 -ethyl-17 -ethynyl-17 -hydroxy-4-gonen-3-one released from polydimethylsiloxane capsules.
D000818:Animals; D002214:Capsules; D003692:Delayed-Action Preparations; D005260:Female; D007279:Injections, Subcutaneous; D009644:Norgestrel / Q000008:administration & dosage* / Q000378:metabolism / Q000494:pharmacology; D010053:Ovary / Q000187:drug effects; D011374:Progesterone / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology; D011372:Progestins / Q000008:administration & dosage* / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D012826:Silicone Elastomers
D002214:Capsules; D003692:Delayed-Action Preparations; D011372:Progestins; D012826:Silicone Elastomers; D009644:Norgestrel; D011374:Progesterone